The Liver Meeting 2019-Treatment of HCV in PWID

Video Transcription

Video Summary

The speaker discussed the treatment of people who actively inject drugs for hepatitis C, highlighting the challenges and effectiveness of treatment in this population. They emphasized the importance of considering integrated care centers for treatment to achieve global elimination goals. The use of harm reduction services, such as opioid substitution therapy and needle exchange programs, was also discussed as critical in reducing transmission rates. Additionally, the impact of iron on non-invasive techniques like MRE was touched upon, suggesting a need for adjustments in patients with iron overload. The role of statins in liver disease management, particularly in cirrhotic patients, was explored, with recommendations for standard dosages and cautious monitoring. The session also addressed splenic artery embolization in specific cases of hypersplenism but not in the acute management of gastric variceal bleeding.

Asset Caption

Presenter: Paul J. Thuluvath

Keywords

hepatitis C treatment

integrated care centers

harm reduction services

iron overload and MRE

statins in liver disease management

cirrhotic patients

splenic artery embolization